Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in MiceJun Yoshino, Shin‐ichiro Imai, Kathryn F. Mills et al.|Cell Metabolism|2011Cited by 1.3k
Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD <sup>+</sup> BiosynthesisKathryn Moynihan Ramsey, Joseph Bass, Jun Yoshino et al.|Science|2009Cited by 1.1k
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NRJun Yoshino, Shin‐ichiro Imai, Joseph A. Baur|Cell Metabolism|2017Cited by 1k
Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in MiceKathryn F. Mills, Shin‐ichiro Imai, Shohei Yoshida et al.|Cell Metabolism|2016Cited by 900
Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with ObesityFaidon Magkos, Samuel Klein, Gemma Fraterrigo et al.|Cell Metabolism|2016Cited by 866